Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 84 citing articles:

Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis
Li Xing, Shizhang Wei, Shengqi Niu, et al.
Computers in Biology and Medicine (2022) Vol. 144, pp. 105389-105389
Closed Access | Times Cited: 255
Polymeric Polylactic Acid–Glycolic Acid-Based Nanoparticles Deliver Nintedanib Across the Blood–Brain Barrier to Inhibit Glioblastoma Growth
Ying Dang, Zhi‐Wen Zhao, Bo Wang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 443-443
Open Access | Times Cited: 1
Surface plasmon resonance aptasensor based on niobium carbide MXene quantum dots for nucleocapsid of SARS-CoV-2 detection
Rongyuan Chen, Lun Kan, Fenghe Duan, et al.
Microchimica Acta (2021) Vol. 188, Iss. 10
Open Access | Times Cited: 79
Research progress of traditional Chinese medicine against COVID-19
Wei Ren, Pan Liang, Yue Ma, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111310-111310
Open Access | Times Cited: 69
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Efficacy and mechanisms of traditional Chinese medicine for COVID-19: a systematic review
Xiaomin Kang, De Jin, Linlin Jiang, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 54
Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis
Linyan Wang, Zhongyan Du, Guan Yang, et al.
Chinese Herbal Medicines (2022) Vol. 14, Iss. 2, pp. 283-293
Open Access | Times Cited: 29
A network pharmacology approach and experimental validation to investigate the anticancer mechanism of Qi-Qin-Hu-Chang formula against colitis-associated colorectal cancer through induction of apoptosis via JNK/p38 MAPK signaling pathway
Yuguang Wu, Yulai Fang, Yanan Li, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117323-117323
Open Access | Times Cited: 20
A Triple-Targeted Rutin-Based Self-Assembled Delivery Vector for Treating Ischemic Stroke by Vascular Normalization and Anti-Inflammation via ACE2/Ang1-7 Signaling
Tingkui Zhao, Fujin He, Ke‐Qing Zhao, et al.
ACS Central Science (2023) Vol. 9, Iss. 6, pp. 1180-1199
Open Access | Times Cited: 16
Multi-ligand molecular docking, simulation, free energy calculations and wavelet analysis of the synergistic effects between natural compounds baicalein and cubebin for the inhibition of the main protease of SARS-CoV-2
Hong Li, Akari Komori, Mingdi Li, et al.
Journal of Molecular Liquids (2023) Vol. 374, pp. 121253-121253
Open Access | Times Cited: 15
Network pharmacology and in vitro experimental verification unveil glycyrrhizin from glycyrrhiza glabra alleviates acute pancreatitis via modulation of MAPK and STAT3 signaling pathways
Rui Zhang, Aiminuer Asikaer, Qi Chen, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic
Wan‐Yi Ho, Zi-han Shen, Yijing Chen, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30080-e30080
Open Access | Times Cited: 5
Study on the mechanism of Trichosanthes kirilowii Maxim. against COPD based on serum chemical composition analysis, network pharmacology, and experimental study
Pengliang Shi, Boyu Zheng, Yanjun Cao, et al.
Phytomedicine (2025) Vol. 140, pp. 156533-156533
Closed Access
Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes)
Evgeni Gusev, Alexey Sarapultsev, Desheng Hu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7582-7582
Open Access | Times Cited: 36
Exploration of the potential mechanism of Banxia Xiexin Decoction for the effects on TNBS-induced ulcerative colitis rats with the assistance of network pharmacology analysis
Weiwei Wang, Congcong Xu, Xinye Li, et al.
Journal of Ethnopharmacology (2021) Vol. 277, pp. 114197-114197
Closed Access | Times Cited: 35
Add-on effect of Chinese herbal medicine in the treatment of mild to moderate COVID-19: A systematic review and meta-analysis
Xuqin Du, Shi Lipeng, Wenfu Cao, et al.
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0256429-e0256429
Open Access | Times Cited: 33
Screening S protein – ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19
Le-le Ma, Huimin Liu, Xuemei Liu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113857-113857
Open Access | Times Cited: 33
A strategy of screening and binding analysis of bioactive components from traditional Chinese medicine based on surface plasmon resonance biosensor
Diya Lv, Jin Xu, Minyu Qi, et al.
Journal of Pharmaceutical Analysis (2021) Vol. 12, Iss. 3, pp. 500-508
Open Access | Times Cited: 32
Surface plasmon resonance as a fascinating approach in target-based drug discovery and development
Shibam Das, Sukhwinder Singh, Viney Chawla, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 171, pp. 117501-117501
Closed Access | Times Cited: 13
Potential Treatment of COVID-19 with Traditional Chinese Medicine: What Herbs Can Help Win the Battle with SARS-CoV-2?
Lin Li, Yuzheng Wu, Jiabao Wang, et al.
Engineering (2021) Vol. 19, pp. 139-152
Open Access | Times Cited: 30
Application of network pharmacology in the study of the mechanism of action of traditional chinese medicine in the treatment of COVID-19
Shihao Zheng, Tianyu Xue, Bin Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Traditional Chinese Medicines Against COVID-19
Chang-Liang Yao, Wenlong Wei, Jian-Qing Zhang, et al.
World Journal of Traditional Chinese Medicine (2022) Vol. 8, Iss. 3, pp. 279-313
Open Access | Times Cited: 19
Development of SARS-CoV-2 entry antivirals
Meiyue Dong, Jazmin Galván Achi, Ruikun Du, et al.
Cell Insight (2024) Vol. 3, Iss. 1, pp. 100144-100144
Open Access | Times Cited: 3
Updated pharmacological effects of Lonicerae japonicae flos, with a focus on its potential efficacy on coronavirus disease–2019 (COVID-19)
Hui Zhao, Sha Zeng, Li Chen, et al.
Current Opinion in Pharmacology (2021) Vol. 60, pp. 200-207
Open Access | Times Cited: 25
Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines
Ying Wu, Ping Zhong
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top